Related Experiment Video
Updated: Jun 28, 2026
07:21
Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
Published on: May 2, 2022
[Gastrointestinal stromal tumors. An update]
Pablo Bórquez Ma1, Rodrigo Neveu C
1Instituto Nacional del Cancer. tellomora@yahoo.es
Revista Medica De Chile
|October 25, 2008
Summary
Gastrointestinal stromal tumors (GIS) are CD 117-positive tumors with variable behavior. Molecular therapies like imatinib have improved survival, and this review covers prognostic factors and treatment options.
Area of Science:
- Oncology
- Gastroenterology
- Molecular Biology
Background:
- Gastrointestinal stromal tumors (GIS) are a heterogeneous group of neoplasms expressing CD 117.
- These tumors can range from benign to highly aggressive, impacting patient prognosis.
- Recent advancements in molecular therapies have significantly improved survival rates for patients with GIS.
Purpose of the Study:
- To analyze prognostic factors and clinical features of GIS.
- To define criteria for identifying malignant behavior in GIS.
- To discuss the efficacy of various therapeutic alternatives, including molecular therapies.
Main Methods:
- Review of existing literature on GIS.
- Analysis of prognostic indicators and clinical presentation.
- Evaluation of therapeutic strategies: radiotherapy, chemotherapy, and molecular targeted therapies.
Main Results:
- Identification of key prognostic factors influencing GIS behavior.
- Established criteria for assessing the malignant potential of GIS.
- Demonstrated improved patient survival with targeted molecular therapies.
Conclusions:
- Understanding prognostic factors is crucial for managing GIS.
- Molecular therapies represent a significant advancement in GIS treatment.
- A comprehensive approach considering clinical features and therapeutic options is essential for optimal patient outcomes.
Related Concept Videos
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...